Ignite Creation Date:
2025-12-25 @ 3:22 AM
Ignite Modification Date:
2025-12-29 @ 5:00 AM
Study NCT ID:
NCT00393705
Status:
COMPLETED
Last Update Posted:
2010-07-20
First Post:
2006-10-26
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Lispro Mid Mixture (MM) Intensive Mixture Therapy With Progressive Dose-Titration of Lispro Low Mixture (LM) or Biphasic Insulin Aspart 30/70 (S019)
Sponsor:
Eli Lilly and Company
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-10
Start Date Type:
None
Primary Completion Date:
2009-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2009-03
Completion Date Type:
ACTUAL
First Submit Date:
2006-10-26
First Submit QC Date:
None
Study First Post Date:
2006-10-30
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2010-03-31
Results First Submit QC Date:
None
Results First Post Date:
2010-04-27
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2010-07-15
Last Update Post Date:
2010-07-20
Last Update Post Date Type:
ESTIMATED